Skip to Content

M GP2 (Glipizide Extended-Release 2.5 mg)

Pill with imprint M GP2 is Blue, Round and has been identified as Glipizide Extended-Release 2.5 mg. It is supplied by Mylan Pharmaceuticals Inc..

Glipizide is used in the treatment of diabetes, type 2 and belongs to the drug class sulfonylureas. Risk cannot be ruled out during pregnancy. Glipizide 2.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M GP2

Glipizide extended-release 2.5 mg M GP2

Glipizide Extended-Release

Imprint
M GP2
Strength
2.5 mg
Color
Blue
Shape
Round
Availability
Prescription only
Drug Class
Sulfonylureas
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
National Drug Code (NDC)
00378-0340

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.